4.7 Editorial Material

Obesity and Breast Cancer Outcomes: How Much Evidence Is Needed to Change Practice?

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 34, Issue 7, Pages 646-+

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2015.64.7503

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

Hongchao Pan, Richard Gray, Jeremy Braybrooke, Christina Davies, Carolyn Taylor, Paul McGale, Richard Peto, Kathleen I. Pritchard, Jonas Bergh, Mitch Dowsett, Daniel F. Hayes

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Editorial Material Geriatrics & Gerontology

Journal Club

P. Dovjak

ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE (2018)

Meeting Abstract Oncology

The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401).

Jennifer A. Ligibel, William Thomas Barry, Catherine M. Alfano, Dawn L. Hershman, Melinda L. Irwin, Marian Neuhouser, Cynthia A. Thomson, Linda Delahanty, Elizabeth Frank, Patricia Spears, Electra D. Paskett, Judith O. Hopkins, Vanessa Bernstein, Vered Stearns, Julia R. White, Thomas Wadden, Pamela Jean Goodwin, Lisa A. Carey, Ann Partridge, Eric P. Winer

JOURNAL OF CLINICAL ONCOLOGY (2018)

Meeting Abstract Oncology

The effect of metformin on sex hormones in non diabetic breast cancer patients in CCTG MA.32: A Phase III randomized adjuvant trial of metformin versus placebo in addition to standard therapy.

Isabel Pimentel, Bingshu E. Chen, Ana Elisa Lohmann, Marguerite Ennis, Jennifer A. Ligibel, Lois E. Shepherd, Dawn L. Hershman, Vuk Stambolic, Ingrid A. Mayer, Timothy J. Hobday, Julie Lemieux, Alastair Mark Thompson, Priya Rastogi, Karen A. Gelmon, Timothy Joseph Whelan, Manuela Rabaglio-Poretti, Ryan Jo Dowling, Wendy R. Parulekar, Pamela Jean Goodwin

JOURNAL OF CLINICAL ONCOLOGY (2019)

Editorial Material Oncology

Obesity and Breast Cancer: Expanding the Hypothesis Space

Ana Elisa Lohmann, Pamela J. Goodwin

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Editorial Material Oncology

Diabetes and Cancer: Unraveling the Complexity

Pamela J. Goodwin

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Oncology

Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial

Pamela J. Goodwin, Ryan J. O. Dowling, Marguerite Ennis, Bingshu E. Chen, Wendy R. Parulekar, Lois E. Shepherd, Margot J. Burnell, Rachel Vander Meer, Andrea Molckovsky, Anagha Gurjal, Karen A. Gelmon, Jennifer A. Ligibel, Dawn L. Hershman, Ingrid A. Mayer, Timothy J. Whelan, Timothy J. Hobday, Priya Rastogi, Manuela Rabaglio-Poretti, Julie Lemieux, Alastair M. Thompson, Daniel W. Rea, Vuk Stambolic

Summary: The study demonstrates that metformin compared to placebo leads to significant weight and metabolic improvements in breast cancer patients, with no influence from baseline BMI or insulin, and no differences based on the rs11212617 allele status.

NPJ BREAST CANCER (2021)

Article Oncology

Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis

Martin C. Chang, Zohreh Eslami, Marguerite Ennis, Pamela J. Goodwin

Summary: Crown-like structures of the breast (CLS-B) are positively correlated with older age, obesity, dyslipidemia, and higher levels of metabolic factors, while different methods of detecting CLS-B show different associations with metabolic factors, disease-free survival, and overall survival. Further research is needed to understand the biological basis for these differences.

NPJ BREAST CANCER (2021)

Article Oncology

The Futility of Futility Analyses in Adjuvant Trials in Hormone Receptor-Positive Breast Cancer COMMENT

Ana Elisa Lohmann, Marguerite Ennis, Wendy R. Parulekar, Bingshu E. Chen, George Tomlinson, Pamela J. Goodwin

Summary: Interim analysis plays a role in terminating exposure to ineffective or unsafe drugs while identifying effective treatments. However, in breast cancer treatment, early analysis may overlook the effects that can only be observed with longer follow-up.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Editorial Material Oncology

Flashback Foreword: Anti-HER2 Monoclonal Antibody as a Single Agent

Pamela J. Goodwin

JOURNAL OF CLINICAL ONCOLOGY (2023)

Meeting Abstract Oncology

Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin versus placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32).

Dawn L. Hershman, Bingshu E. Chen, Wendy R. Parulekar, Julie Lemieux, Jennifer A. Ligibel, Karen A. Gelmon, Timothy Joseph Whelan, Pamela Jean Goodwin

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo

Pamela J. Goodwin, Ryan J. O. Dowling, Marguerite Ennis, Bingshu E. Chen, Wendy R. Parulekar, Lois E. Shepherd, Karen A. Gelmon, Timothy J. Whelan, Jennifer A. Ligibel, Dawn L. Hershman, Ingrid A. Mayer, Timothy J. Hobday, Priya Rastogi, Manuela Rabaglio-Poretti, Julie Lemieux, Alastair M. Thompson, Daniel W. Rea, Vuk Stambolic

Summary: The study showed that metformin significantly reduces CA 15-3 levels in early-stage breast cancer patients. This reduction is independent of tumor characteristics and treatment methods.

JNCI CANCER SPECTRUM (2021)

Article Oncology

The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer

Pamela J. Goodwin, Roanne J. Segal, Michael Vallis, Jennifer A. Ligibel, Gregory R. Pond, Andre Robidoux, Brian Findlay, Julie R. Gralow, Som D. Mukherjee, Mark Levine, Kathleen I. Pritchard

NPJ BREAST CANCER (2020)

Meeting Abstract Oncology

Association of obesity with breast cancer outcome in relation to cancer subtypes.

Ana Elisa Lohmann, Sara V. Soldera, Isabel Pimentel, Domen Ribnikar, Marguerite Ennis, Eitan Amir, Pamela Jean Goodwin

JOURNAL OF CLINICAL ONCOLOGY (2019)

Meeting Abstract Medicine, Research & Experimental

Leptin-Receptor Expression in Luminal-Type Breast Carcinoma Is Associated with Pathologic Features of Diffuse Risk but Not with Tumor Proliferation

Blerta Starova, Mandi Rahimi, Marguerite Ennis, Ryan J. O. Dowling, Vuk Stambolic, Pamela J. Goodwin, Martin C. Chang

LABORATORY INVESTIGATION (2017)

No Data Available